Varian ProBeam360° Proton Therapy System China Clinical Trial (Wuhan)
Sponsor: Varian, a Siemens Healthineers Company
A NA clinical study on Tumor, Solid, this trial is completed. The trial is conducted by Varian, a Siemens Healthineers Company and has accumulated 5 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
5 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
Status: Recruiting → Completed
-
Oct 2024 — Jan 2026 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Varian, a Siemens Healthineers Company
For direct contact, visit the study record on ClinicalTrials.gov .